ERBB2 and breast cancer: Long-term survivors in cases of metastatic BC in general are typically younger at the diagnosis of metastatic disease, are premenopausal and the most common biological subtype is estrogen receptor -positive, progesterone receptor-positive, and HER2-positive [18].